In the matched cohort, baseline characteristics, including gender, age, primary tumor site, primary tumor T stage, primary tumor lymph node status, RAS mutation, disease-free interval, number of liver metastases, distribution of liver metastases, maximum tumor diameter, and CEA level were all balanced. The gene discussed is CEACAM5; the disease is neoplasm.